Strong debut: 68% YoY growth, ₹1,180 Cr order book, ambitious ₹1,000 Cr FY30 target
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
First public call; delivered H1 ₹210 Cr matches ₹210 Cr H1 guidance. No prior guidance to miss/beat.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong growth (68% YoY), order-book-backed expansion, and multi-year 30–35% CAGR guidance support long-term thesis. Near-term risks: recent IPO ramp, product-mix-driven margin compression (gross margin 59%→53%), and execution on capacity expansion. PAT margin 11.8% delivered, in line with 12% H1 guided; EBITDA margin 19% sustainable. Hold pending clarity on non-auto margin accretion and WC cycle normalization.
₹210.1 Cr
Revenue · +68% YoY₹24.9 Cr
Reported PAT · +88% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Non-auto revenue grew 194% YoY
OVERSTATEDNon-auto ₹48 Cr H1 FY27 vs ₹17 Cr H1 FY26 = 183% growth
H1 revenue 68% YoY
MET₹210 Cr H1 FY27 vs ₹125 Cr H1 FY26 = 68% verified
PAT CAGR 44.2% FY24–26
MET₹16 Cr FY24 to ₹34 Cr FY26 = 46% CAGR; claim 44.2% is plausible
50% FY27 growth target
MET₹210.1 Cr Q2 result. If sustained ~₹420 Cr FY27, vs ₹294 Cr FY26 = 43% achieved-to-date, on track
Earnings quality
What changed since the last call
Non-auto revenue acceleration
UpgradeNon-auto segment grew 183% YoY to ₹48 Cr (25% of H1 revenue, up from 15% in H1 FY26). Management reaffirms 50:50 target by FY30.
Capacity roadmap confirmed
UpgradeIPO capital deployed; 28.8k melting + 12.6k casting tons by FY28 (vs. current 13.8k + 6k). Unit 3 20% capacity live, full utilization Sep 2027.
Gross margin pressure
Downgrade59% → 53% due to shift to larger, lower-margin components. Offset claimed via non-auto mix but timing/magnitude unclear.
Order book visibility
Upgrade₹1,180 Cr order book (first disclosure); 52% auto, 48% non-auto. Breaks down to ~₹630–640 Cr next year, ₹800 Cr after, ₹820–1,000 Cr by 2030.
The Q&A
Q&A was substantive; analysts pressed on margins, working capital, capacity utilization, and aerospace timelines. Management largely direct, though hedged on non-auto margin specifics and withheld customer names due to NDAs. No defensive tone; candid on RM volatility and margin trajectory.
Order book deployment — Prithvi, Abakkus Investment Managers
Answered52% auto, 48% non-auto. Next year ₹630–640 Cr, year after ₹800 Cr, by 2030 ₹820–1,000 Cr. Backed by capacity expansion.
Capacity utilization & ramp — Prithvi, Abakkus Investment Managers
AnsweredCurrent 71–72% utilization before Unit 3. 20% of Unit 3 capacity (110 tons) installed, rest by Sep 2027. Full utilization path to 82%.
Aerospace & defence approval — Siddhanth, OneUp
AnsweredHAL approved prototype parts; Nashik foundry & Indian Air Force also approved. Vendor code secured. Minimum 4 years for certifications; no production sales currently indicated.
Working capital normalization — Sahil Jain, Ashvi India Holdings
Answered45-day cycle (die + tooling design lag). Current ₹60 Cr inventory, ₹42 Cr last-month sales = 1.5 months. Will stabilize; not seasonal business.
Non-auto margin outlook — Tanmay Jhaveri, Finterest Capital
PartialCurrently 60% non-auto, 40% auto margins. Increase in non-auto participation will expand overall margins. Specific % deferred.
Gross margin compression drivers — Ayush Oswal, Vardhman Family Office
AnsweredProduct mix shift to 50–80 kg components (vs. 1–9 kg). Margin pressure but management offsetted via overall margin expansion.
FY27 growth guidance conservatism — Ashish Chansikar, Wealthyvia Ventures
AnsweredH1 typically 43–47% of annual revenue (not seasonal). H1 68% growth ≠ annualized. 50% is achievable; FY27–30 guidance 30–35%.
INR 1,000 Cr target credibility — Abhi Jain, AJ Capital
AnsweredOrder book ₹1,180 Cr currently; RFQs ₹2,000 Cr+ annually. 8–10% strike rate. No hesitation in achieving ₹1,000 Cr.
Revenue per ton dynamics — Divyansh Agarwal, Ionic Asset Managers
AnsweredMix (larger, precision components) + RM pass-through. Combination of factors.
Magnesium R&D timeline — Rudraksh Raheja, Ithought PMS
AnsweredPrototype phase; 2-year timeline for finalization. No production revenue indicated yet.
Guidance
FY27: 50% CAGR target
HighH1 delivered ₹210.1 Cr; ₹294 Cr FY26 base. 50% = ~₹441 Cr FY27 target. Order book ₹1,180 Cr backing.
FY27–FY30: 30–35% CAGR
HighTargets ₹1,000 Cr by FY30. Order book + RFQs (₹2,000+ Cr, 8–10% strike) + capacity expansion support.
Order book deployment: ₹630–640 Cr next year, ₹800 Cr +1, ₹820–1,000 Cr by 2030
HighCurrent ₹1,180 Cr visible; backed by 52% auto, 48% non-auto mix.
EBITDA margin 19% sustainable
MediumH1 delivered 19%; dependent on non-auto mix accretion and fixed-cost absorption post-Unit 3 ramp.
PAT margin 12% (from 11.4% FY26)
HighH1 delivered 12%. Post-IPO debt repayment by Q2 will reduce finance costs; variable costs to drive expansion.
Gross margin recovery via non-auto mix
LowCurrently 53% (compressed from 59%). Non-auto expansion claimed to offset, but timeline/magnitude unclear.
Unit 3 capacity (6.6k tons casting) completion by Sep 2027
High20% already installed; machines on order; expected completion by Sep 2027. Capex ~₹40–50 Cr estimated.
Total capacity 28.8k melting + 12.6k casting tons by FY28
HighNearly doubles from 13.8k + 6k. IPO proceeds financing expansion. Utilization path to 82%.
Risks the call surfaced
Customer concentration
Medium52% of H1 revenue from automotive OEMs (2-wheelers, 3-wheelers, CVs, passenger vehicles). Downturn in auto production or customer loss would impact top-line.
Gross margin compression
MediumGross margin fell 59% (FY26) → 53% (H1 FY27) due to product-mix shift (1–9 kg→50–80 kg components). Larger, precision components have lower gross margins initially.
RM price volatility
LowAluminium price jumped USD 2,800→3,300/ton (~18% rise). LPDC technology relies on aluminium alloys. Price volatility could compress margins if not fully passed through.
Capacity ramp execution
MediumUnit 3 expansion (6.6k tons casting) to reach 82% utilization by Sep 2027. Delay or cost overrun could extend fixed-cost absorption and margin pressure.
Aerospace R&D timeline
LowAerospace & defence segment (HAL, IAF approvals) in prototype phase. 4-year certification cycle before production sales. No revenue visible; timing risk if certifications extend.
Management
Score 7/10. Clear, detailed on strategy (non-auto diversification, capacity roadmap, order book), but hedged on margin specifics (non-auto % accretion, gross margin recovery timeline unquantified). Strong track record: 30% CAGR FY24–26, 44% PAT CAGR. H1 FY27 delivered ₹210.1 Cr matches guidance. IPO capital deployment on track (Unit 3 20% live).
1 · Sep 2027
Unit 3 capacity ramp to full 82% utilization; fixed-cost absorption margin lift
2 · FY27-28
New orders from Fortune 500 via Poojaa as marketing channel; non-auto revenue acceleration
3 · 4Q FY27
Aerospace certification milestones (HAL, IAF, vendor code); 4-year path to production sales
Hold pending clarity on non-auto margin accretion and WC cycle normalization.
Informational and educational content only. Not investment advice.